SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000912057-01-005921
Filing Date
2001-02-14
Accepted
2001-02-14 00:00:00
Documents
1
Group Members
BIOTECHNOLOGY VALUE FUND II, L.P.BIOTECHNOLOGY VALUE FUND L PBVF INC.BVF INVESTMENTS, L.L.C.BVF PARTNERS L.P.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G a2038566zsc13ga.txt SC 13G/A 22373
  Complete submission text file 0000912057-01-005921.txt   24703
Mailing Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553-3649
Business Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553 5162220023
OSI PHARMACEUTICALS INC (Subject) CIK: 0000729922 (see all company filings)

IRS No.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13G/A | Act: 34 | File No.: 005-37954 | Film No.: 1546255
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice